OSBPL3 is vital for fatty liver disease, but its immune mechanisms in metabolic dysfunction-associated steatotic liver disease (MASLD) are unclear. This evidence concerns the gene OSBPL3 and metabolic dysfunction-associated steatotic liver disease.